Home >> Tag Archives: Genomic Health

Tag Archives: Genomic Health

Exact Sciences to buy Genomic Health for $2.8 billion

July 29, 2019–Exact Sciences and Genomic Health announced today that the companies have entered into a definitive agreement in which Exact Sciences will combine with Genomic Health for $2.8 billion. The two companies will create a worldwide cancer diagnostics company, joining its two brands Cologuard and Oncotype DX, respectively. The combined company expects to generate revenue of approximately $1.6 billion and gross profit of approximately $1.2 billion in 2020.

Read More »

Genomic Health, Epic Sciences collaboration, 9/16

September 2016—Genomic Health and Epic Sciences announced an exclusive agreement to commercialize Epic Sciences’ novel AR-V7 liquid biopsy test in the U.S. through Genomic Health’s commercial channel. The blood-based test detects the V7 variant of the androgen receptor protein in the nucleus of circulating tumor cells—information that can help guide treatment selection in patients with metastatic castration-resistant prostate cancer.

Read More »
CAP TODAY
X